Journal of Endocrinological Investigation

, Volume 17, Issue 10, pp 805–808 | Cite as

Elevation of cord blood TSH concentration in newborn infants of mothers exposed to acute povidone iodine during delivery

  • M. NovaesJr.
  • M. M. Biancalana
  • S. A. Garcia
  • I. Rassi
  • J. H. Romaldini


The thyroid function in full term newborn infants of 30 pregnant women given topical germicide providine-iodine (PVPI) during delivery was evaluated. For comparison 12 full term newborn infants of pregnant women using clorhexidine hydrochloride as germicide in selective cesarean section were designed as control. The two pregnant groups had similar median age (27.5 yr in PVPI group, range: 19–42 yr and 28.5 yr in control group, 19–40 yr) and gestational age (39 weeks, 38–42 weeks and 39.5 weeks, 38–42 weeks). Birth weight (3365 g, 2500–3860 g and 3265 g, 2850–4000 g) and the apgar score (9, 9–10 and 9, 8–10) of newborn were similar in both groups. Umbilical cord blood samples were taken after immediate clamping and serum total T3, total T4, free T4 and TSH concentrations were assayed by an immunofluorimetric method. T3, T4 and free T4 concetrations in the cord blood were not different in PVPI newborn infants (median values: 0.92 nmol/L., 135 nmol/L., and 15.9 pmol/L), in comparison to control newborns (0.97 mmol/L., 140.9 nmol/L and 17.3 pmol/L). In contrast, cord blood TSH concentration in newborn infants of PVPI pregnant women (median value: 6.47 mlU/L) was significantly higher (p<0.01) than in control newborn infants (4.8 mlU/L). In PVPI exposed group 14 out of 30 newborn infants had TSH concentration above the upper value (6.7 mlU/L) observed in the control groups (X2 = 8.4, p<0.01). These data suggest that fetal thyroid is susceptible even to acute iodine overload and support the recommendation that PVPI should be avoided during pregnancy.


Congenital hypothyroidism thyroid hormone iodine pregnancy thyrotropin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Biancalana M.M., Novaes M. Jr., Dualibi L., Werner R.S. Transient neonatal hyperthyrotropinemia. In: Gordon A., Gross J., Hennemann G. (eds.), Progress in Thyroid Research. Balkema, Rotterdam, p. 181, 1991.Google Scholar
  2. 2.
    Robuschi G., Montermini M., Alboni A., Borciani E., Cersosimo G., Negrotti L., Gnudi A., Safran M., Braverman L.E., Roti E. Cord blood iodothyronine and thyrotropin concentration in newborns of mothers exposed to povidone iodine in the last trimester. J. Endocrinol. Invest. 10: 183, 1987.PubMedCrossRefGoogle Scholar
  3. 3.
    Danziger Y., Pertzelan A., Mimouni M. Transient congenital hypothyroidism after topical iodine in pregnancy and lactation. Arch. Dis. Child. 62: 295, 1987.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Pharoah P.O.D., Connolly K.J. Effects of maternal iodine supplementation during pregnancy. Arch. Dis. Child. 66: 145, 1991.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Gruters A., L’Allemand D., Heidemann P.H., Schurnbrand P. Incidence of iodine contamination in neonatal transient hyperthyrotropinemia. Eur. J. Pediatric 140: 299, 1983.CrossRefGoogle Scholar
  6. 6.
    Bachrach L.K., Burrow G.N., Gare DJ. Maternal-fetal absorption of povidone-iodine. J. Pediatr. 104: 159, 1984.CrossRefGoogle Scholar
  7. 7.
    Jackson H.J., Sutherland R.N. Effect of povidone-iodine on neonatal thyroid function Lancet 2: 992, 1981.PubMedCrossRefGoogle Scholar
  8. 8.
    Lyen K.R., Finegold D., Orsini R., Herd J.E., Parks J.S. Transient thyroid suppression associated with topically applied povidone-iodine. Am. J. Dis. Child 136: 369, 1982.PubMedGoogle Scholar
  9. 9.
    Penington JAT. A review of iodine toxicity reports. J. Amer. Diet. Assoc. 90: 1571, 1990.Google Scholar
  10. 10.
    Safran M., Braverman L.E. Effect of chronic douching with polyvinylpyrrolidone-iodine on iodine absorpition and thyroid function. Obstet Gynecol 60: 35, 1982.PubMedGoogle Scholar
  11. 11.
    Chabrolle J.P., Rossier A. Goiter and hypothyroidism in the newborn after cutaneous absorption of iodine. Arch. Dis. Child. 53: 495, 1978.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Pyati S.P., Ramamurthy R.S., Krauss T.M., Pildes R.S. Absorption of iodine in the neonatal following topical use of povidone iodine. J. Pediatr. 91: 825, 1977.PubMedCrossRefGoogle Scholar
  13. 13.
    Fisher D.A. Effectiveness of newborn screening program for congenital hypothyroidim: prevalence of missed cases. Ped.Clin. N. Am. 34: 881, 1987.Google Scholar
  14. 14.
    Lager J. Screening for congenital hypothyroidism in France. Eur. J. Pediatr. 149: 605, 1990.CrossRefGoogle Scholar
  15. 15.
    Iancu T., Boyanover Y., Laurian N. Congenital goiter due to maternal ingestion of iodine. Am. J. Dis. Child 128: 528, 1974.PubMedGoogle Scholar
  16. 16.
    Wolff J. Iodine goiter and the pharmacologic effects of excess iodine. Am. J. Med. 47: 101, 1969.PubMedCrossRefGoogle Scholar
  17. 17.
    Fisher DA, Klein A. Thyroid development and disorders of thyroid function in the newborn. N. Engl. J. Med. 304: 702, 1981.PubMedCrossRefGoogle Scholar
  18. 18.
    Theodoropoulos T., Braverman L.E., Vagenakis A.G. Iodine-induced hypothyroidism: A potential hazard during perinatal life. Science 205: 502, 1979.PubMedCrossRefGoogle Scholar
  19. 19.
    Medeiros-Neto G.A. Towards the eradication of iodine deficiency disorders in Brazil though a salt iodination programme. Bull World Health Org. 66: 637, 1988.PubMedCentralPubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1994

Authors and Affiliations

  • M. NovaesJr.
    • 1
  • M. M. Biancalana
    • 1
  • S. A. Garcia
    • 1
  • I. Rassi
    • 1
  • J. H. Romaldini
    • 1
  1. 1.Department of Endocrinology and Department of ObstetricsHospital Servidor Pubblico, IAMSPESao PauloBrazil

Personalised recommendations